
Novel Therapies in Management of Haemolytic Disease of the Fetus and Newborn, reveals research
Haemolytic disease of the fetus and newborn (HDFN) occurs when there is transplacental passage of maternal immunoglobulin G (IgG) red cell antibodies, which bind to paternally-derived antigens on fetal red blood cells, or alternatively those of a donor …